Back to Search
Start Over
Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial.
- Source :
-
American journal of medical genetics [Am J Med Genet] 1997 Jan 31; Vol. 68 (3), pp. 311-4. - Publication Year :
- 1997
-
Abstract
- Patients with the RSH or Smith-Lemli-Optiz syndrome (SLOS) have an inborn error of cholesterol biosynthesis which results in a deficiency of cholesterol and an elevation of the cholesterol precursor, 7-dehydrocholesterol. A treatment protocol consisting of administration of cholesterol +/- bile acids was initiated in an attempt to correct the biochemical abnormalities seen. Fourteen patients (8 female, 6 male: ages 2 months to 15 years) have now been treated for 6-15 months. Three patients received cholesterol alone, while 11 patients received cholesterol and one or more bile acids. Biochemical improvement in sterol levels and in the ratio of cholesterol to total sterols was noted in all patients. The most marked improvement was noted in patients presenting with initial cholesterol levels < 40 mg/dl. No toxicity was observed. Clinical improvement in growth and neurodevelopmental status was also observed.
- Subjects :
- Adolescent
Bile Acids and Salts adverse effects
Child
Child, Preschool
Cholesterol adverse effects
Cholesterol blood
Clinical Protocols
Drug Therapy, Combination
Female
Humans
Infant
Male
Smith-Lemli-Opitz Syndrome blood
Sterols blood
Bile Acids and Salts therapeutic use
Cholesterol therapeutic use
Smith-Lemli-Opitz Syndrome drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0148-7299
- Volume :
- 68
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- American journal of medical genetics
- Publication Type :
- Academic Journal
- Accession number :
- 9024565